Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20…

Overview of attention for article published in Clinical Cardiology: International Journal for Cardiovascular Diseases, September 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

policy: 1 policy source
twitter: 2 X users

patent: 28 patents
facebook: 1 Facebook page

Readers on

mendeley: 116 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,046 followers.

New Article Alert: Efficacy and Safety of Alirocumab as Add-on Therapy in High–Cardiovascular-Risk Patients Wi... http://t.co/0VZ7grhzYR

New Article Alert: Efficacy and Safety of Alirocumab as Add-on Therapy in High–Cardiovascular-Risk Patients Wi... http://t.co/0VZ7grhzYR

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.